Inventor · Wellesley, MA, US

Leonard I. Zon

41Patents
6h-index
38Co-inventors
69Inventor score

Filing activity: Dec 23, 1994 → Apr 7, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9040286B2 Diagnosis and treatment of cancer Physics 26 Active
US8168428B2 Method to modulate hematopoietic stem cell growth Chemistry; Metallurgy 21 Active
US7427603B2 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells Chemistry; Metallurgy 11 Expired
US8563310B2 Methods for promoting hematopoietic reconstitution Chemistry; Metallurgy 6 Active
US8551782B2 Methods for promoting HSC engraftment Chemistry; Metallurgy 6 Active
US5700927A Tbc1 gene and uses thereof Human Necessities 6 Expired
US7166448B1 Ferroportin1 nucleic acids and proteins Chemistry; Metallurgy 5 Expired
US10420778B2 Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies Human Necessities 5 Active
US9056085B2 Methods for enhancing hematopoietic stem/progenitor cell engraftment Human Necessities 4 Active
US9028811B2 Methods for promoting HSC self-renewal Chemistry; Metallurgy 4 Active
US9402852B2 Method to enhance tissue regeneration Human Necessities 4 Active
US9051548B2 Methods for enhancing hematopoietic stem/progenitor cell engraftment Chemistry; Metallurgy 3 Active
US7521055B2 Ferroportin1 antibodies and methods Chemistry; Metallurgy 3 Active
US10668039B2 Methods for treatment of adenoid cystic carcinoma Physics 2 Active
US6524833B1 Two sterile-20 kinase-like proteins and methods of use thereof Chemistry; Metallurgy 2 Expired
US11065258B2 Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies Human Necessities 2 Active
US10980808B2 Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies Human Necessities 1 Active
US9737567B2 Methods for enhancing hematopoietic stem/progenitor cell engraftment Chemistry; Metallurgy 1 Active
US11534418B2 Methods and agents that enhance myogenic progenitor cell engraftment Chemistry; Metallurgy 1 Active
US8101412B2 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells Chemistry; Metallurgy 1 Active
US8329175B2 Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders Emerging Cross-Sectional Technologies 1 Active
US6943025B2 Method for identifying genes involved in cell proliferation Human Necessities 0 Expired
US9763980B2 Combined chemical modification of sphingosine-1-phosphate (S1P) and CXCR4 signalling pathways for hematopoietic stem cell (HSC) mobilization and engraftment Human Necessities 0 Active
US10016402B2 Methods for treatment of melanoma Human Necessities 0 Active
US10736906B2 Method to enhance tissue regeneration Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.